PATINA: A randomized open label phase III trial to evaluate the efficacy and safety of palbociclib+ anti HER2 therapy+ endocrine therapy vs anti HER2 therapy+ endocrine therapy after induction treatment for hormone receptor positive, HER2 positive metastatic breast cancer
Proceedings article published in 2018 by
Otto Metzger-Filho,
Sumithra Mandrekar,
Sibylle Loibl,
Eva Ciruelos,
Luca Gianni,
Elgene Lim 
,
Kathy Miller,
Cynthia Huang,
Maria Koehler,
Prue Francis
,
Kathy Miller,
Cynthia Huang,
Maria Koehler,
Prue Francis
